Cbl-b-IN-32
Cbl-b-IN-32 is a Cbl-b inhibitor with an IC50 of 6.83 μM. Cbl-b-IN-32 binds to the TKB-LH interface, stabilizes the inactive conformation of Cbl-b, engages Tyr363 via hydrogen bonds and water bridges, and forms hydrogen bonds with Phe261 and Phe263.
For research use only. We do not sell to patients.
- Formula: C16H17F3N2O
- Molecular Weight:310.31
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
Cbl-b 6.83 μM (IC50) |
In Vitro
Cbl-b-IN-32 (compound 27) (2-50 μM) directly binds to purified His-Cbl-b protein, inducing a concentration-dependent decrease in protein thermal stability with a ΔTm of -7.0 °C at 50 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Molecular Weight 310.31
-
Formula C16H17F3N2O
-
SMILES
O=C1C(C2=CC=CC(C(CCN)C)=C2)=CC(C(F)(F)F)=CN1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Cbl-b-IN-32
- E1/E2/E3 Enzyme
- E1 activating enzyme
- E2 conjugating enzyme
- E3 ligating enzyme
- Ubiquitin activating enzyme
- Ubiquitin conjugating enzyme
- Ubiquitin ligase
- molecular dynamics simulations
- Phe261
- Cbl-b
- His-Cbl-b protein
- protein thermal stability
- PDB ID: 9FQJ
- Tyr363
- fluorescence polarization-based competitive binding assay
- TKB-LH interface
- Phe263
- Inhibitor
- inhibitor
- inhibit